<DOC>
	<DOCNO>NCT00944424</DOCNO>
	<brief_summary>Randomized phase III trial determine effectiveness High dose versus Standard dose Vitamin D2 ( Ergocalciferol ) give Docetaxel patient metastatic breast cancer</brief_summary>
	<brief_title>Phase III Trial High Dose vs. Standard Dose Vit D2 With Docetaxel Met Breast ca</brief_title>
	<detailed_description>2 Arms Randomization patient metastatic breast cancer . Arm A = Docetaxel + High dose Vitamin D2 Arm B = Docetaxel + Standard dose Vitamin D2</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<criteria>Histologically prove metastatic adenocarcinoma breast . Gender : female . Age ≥18 year . ECOG performance status ≤ 2 . ( see appendix I ) 25 ( OH ) Vitamin D level ≤ 100nmol/L ( 40ng/L ) . No 1 prior chemotherapy regimen include Docetaxel Paclitaxel metastatic breast cancer . Patients progress Doxorubicin epirubicin first line metastatic breast cancer eligible . Concurrent bisphosphonate therapy allow . Life expectancy 6 month At least 12 month since prior adjuvant neoadjuvant chemotherapy include Taxanes regimen . Adequate hematologic , hepatic renal function . Written informed consent . Pregnant lactating woman . Male breast cancer . Women childbearing potential unless surgically sterile use adequate measure contraception . Metastatic inflammatory breast cancer . CNS metastasis . Leptomeningeal carcinomatosis . Malignant hypercalcemia . History kidney stone . History active primary hyperparathyroidism . Normal 25 ( OH ) Vitamin D level ≥100 nmol/L ≥ 40 ng/L . Previous concomitant malignancy type , except adequately treat basal cell carcinoma skin situ cervix cancer . Patient antiPsychotic medication Steroid therapy . History malabsorption syndrome ( pancreatic insufficiency , celiac disease tropical sprue ) . Any follow abnormal baseline hematological value : ANC &lt; 1.0 x109/L , platelet &lt; 100.000 x 109/L . Any following abnormal laboratory test : total serum bilirubin &gt; 2.00 x ULN ( upper limit normal ) , AST , ALT &gt; 2.5 x ULN ALP &gt; 2.50 x ULN ( upper limit normal ) .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>Vitamin D patient metastatic breast cancer</keyword>
</DOC>